Literature DB >> 10926178

Fibrosis and angiogenesis.

R Kalluri1, V P Sukhatme.   

Abstract

Research during the past few years has contributed vastly to a better understanding of fibrosis and angiogenesis. Although studies to understand the molecular processes associated with fibrosis and angiogenesis were performed independently of each other, some common parallels have emerged. Translation of these observations into potential therapeutic possibilities needs further exploration.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10926178     DOI： 10.1097/00041552-200007000-00013

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN： 1062-4821            Impact factor:   2.894


  29 in total

1.  A peptide derived from endostatin ameliorates organ fibrosis.

Authors:  Yukie Yamaguchi; Takahisa Takihara; Roger A Chambers; Kristen L Veraldi; Adriana T Larregina; Carol A Feghali-Bostwick
Journal:  Sci Transl Med       Date:  2012-05-30       Impact factor: 17.956

2.  A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.

Authors:  Yogesh M Kulkarni; Sucharita Dutta; Anand Krishnan V Iyer; Rajkumar Venkatadri; Vivek Kaushik; Vani Ramesh; Clayton A Wright; Oliver John Semmes; Juan S Yakisich; Neelam Azad
Journal:  Proteomics       Date:  2015-11-24       Impact factor: 3.984

3.  Mediators leading to fibrosis - how to measure and control them in tissue engineering.

Authors:  Xd Mu; Ih Bellayr; Tj Walters; Y Li
Journal:  Oper Tech Orthop       Date:  2010-06-01

Review 4.  Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.

Authors:  Chun Geun Lee; Hye-Ryun Kang; Robert J Homer; Geoffrey Chupp; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2006-07

5.  Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis.

Authors:  Marek Wagner; Rolf Bjerkvig; Helge Wiig; Juan M Melero-Martin; Ruei-Zeng Lin; Michael Klagsbrun; Andrew C Dudley
Journal:  Angiogenesis       Date:  2012-05-22       Impact factor: 9.596

Review 6.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

7.  Laminin α1 is a genetic modifier of TGF-β1-stimulated pulmonary fibrosis.

Authors:  Chang-Min Lee; Soo Jung Cho; Won-Kyung Cho; Jin Wook Park; Jae-Hyun Lee; Augustine M Choi; Ivan O Rosas; Ming Zheng; Gary Peltz; Chun Geun Lee; Jack A Elias
Journal:  JCI Insight       Date:  2018-09-20

8.  The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure.

Authors:  Tadashi Namisaki; Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Mitsuteru Kitade; Kosuke Kaji; Yusaku Shirai; Yosuke Aihara; Junichi Yoshii; Koji Yanase; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  J Angiogenes Res       Date:  2010-08-24

9.  Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.

Authors:  H Yoshiji; S Kuriyama; J Yoshii; Y Ikenaka; R Noguchi; D J Hicklin; Y Wu; K Yanase; T Namisaki; M Yamazaki; H Tsujinoue; H Imazu; T Masaki; H Fukui
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

10.  Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis.

Authors:  Carla Q Feitoza; Giselle M Gonçalves; Patrícia Semedo; Marcos A Cenedeze; Hélady S Pinheiro; Felipe Caetano Beraldo; Oscar Fernando Pavão dos Santos; Vicente de Paula A Teixeira; Marlene A dos Reis; Marilda Mazzali; Alvaro Pacheco-Silva; Niels O S Câmara
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.